What is the remaining status of adaptive servo-ventilation? The results of a real-life multicenter study (OTRLASV-study) : Adaptive servo-ventilation in real-life conditions.

Adaptive servo-ventilation CPAP Central sleep apnea Chronic heart failure Obstructive sleep apnea Sleep-disordered breathing Treatment emergent central sleep apnea

Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
29 Oct 2019
Historique:
received: 01 08 2019
accepted: 17 10 2019
entrez: 31 10 2019
pubmed: 31 10 2019
medline: 24 4 2020
Statut: epublish

Résumé

As a consequence of the increased mortality observed in the SERVE-HF study, many questions concerning the safety and rational use of ASV in other indications emerged. The aim of this study was to describe the clinical characteristics of ASV-treated patients in real-life conditions. The OTRLASV-study is a prospective, 5-centre study including patients who underwent ASV-treatment for at least 1 year. Patients were consecutively included in the study during the annual visit imposed for ASV-reimbursement renewal. 177/214 patients were analysed (87.57% male) with a median (IQ In real-life conditions, ASV-treatment is often associated with high cardiac comorbidities and high compliance. Future research should assess how regular night monitoring may optimize devices settings and patient management. The OTRLASV study is registered on ClinicalTrials.gov (Identifier: NCT02429986 ) on 1 April 2015.

Sections du résumé

BACKGROUNDS BACKGROUND
As a consequence of the increased mortality observed in the SERVE-HF study, many questions concerning the safety and rational use of ASV in other indications emerged. The aim of this study was to describe the clinical characteristics of ASV-treated patients in real-life conditions.
METHODS METHODS
The OTRLASV-study is a prospective, 5-centre study including patients who underwent ASV-treatment for at least 1 year. Patients were consecutively included in the study during the annual visit imposed for ASV-reimbursement renewal.
RESULTS RESULTS
177/214 patients were analysed (87.57% male) with a median (IQ
CONCLUSIONS CONCLUSIONS
In real-life conditions, ASV-treatment is often associated with high cardiac comorbidities and high compliance. Future research should assess how regular night monitoring may optimize devices settings and patient management.
TRIAL REGISTRATION BACKGROUND
The OTRLASV study is registered on ClinicalTrials.gov (Identifier: NCT02429986 ) on 1 April 2015.

Identifiants

pubmed: 31665026
doi: 10.1186/s12931-019-1221-9
pii: 10.1186/s12931-019-1221-9
pmc: PMC6819598
doi:

Banques de données

ClinicalTrials.gov
['NCT02429986']

Types de publication

Journal Article Multicenter Study Observational Study Pragmatic Clinical Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

235

Références

Sleep Med. 2011 Dec;12(10):952-8
pubmed: 22030207
Am J Respir Crit Care Med. 2001 Aug 15;164(4):614-9
pubmed: 11520725
Circ J. 2012;76(10):2305-17
pubmed: 22972365
Clin Res Cardiol. 2018 Aug;107(8):719-728
pubmed: 29654439
Sleep. 2009 May;32(5):623-8
pubmed: 19480229
J Clin Sleep Med. 2018 Jan 15;14(1):57-63
pubmed: 29198291
Chest. 2010 Jan;137(1):102-8
pubmed: 19820075
Lancet Respir Med. 2016 Nov;4(11):846-847
pubmed: 27592225
Arch Bronconeumol. 2017 Aug;53(8):455-457
pubmed: 28209445
ERJ Open Res. 2017 Oct 23;3(4):null
pubmed: 29204433
Sleep. 2007 Jun;30(6):711-9
pubmed: 17580592
J Clin Sleep Med. 2016 May 15;12(5):757-61
pubmed: 27092695
ESC Heart Fail. 2018 Jun;5(3):222-230
pubmed: 29469206
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
N Engl J Med. 2015 Sep 17;373(12):1095-105
pubmed: 26323938
J Clin Sleep Med. 2019 Jan 15;15(1):119-128
pubmed: 30621843
J Am Coll Cardiol. 2017 Mar 28;69(12):1577-1587
pubmed: 28335841
J Clin Sleep Med. 2017 May 15;13(5):657-664
pubmed: 28095974
Chest. 2014 Aug;146(2):514-523
pubmed: 25091757
Am J Respir Crit Care Med. 2013 Sep 1;188(5):613-20
pubmed: 23992588
Sleep. 2018 Sep 1;41(9):
pubmed: 29471442
Eur Respir J. 2017 Aug 31;50(2):
pubmed: 28860264
Eur Respir J. 2017 Jan 18;49(1):
pubmed: 27920092
J Clin Sleep Med. 2016 Aug 15;12(8):1153-8
pubmed: 27166303
Chest. 2014 Sep;146(3):858-868
pubmed: 25180729
Clin Res Cardiol. 2017 Sep;106(9):702-710
pubmed: 28417254
Sleep. 2012 Jan 01;35(1):17-40
pubmed: 22215916
Sleep. 1999 Aug 1;22(5):667-89
pubmed: 10450601
Heart Rhythm. 2019 Jan;16(1):91-97
pubmed: 30059750
Sleep. 2012 Sep 01;35(9):1277-83A
pubmed: 22942506
Heart Vessels. 2015 Nov;30(6):805-17
pubmed: 25103691

Auteurs

Dany Jaffuel (D)

Department of Respiratory Diseases, Montpellier University Hospital, Hôpital Arnaud de Villeneuve, 371 avenue du Doyen Gaston Giraud, 34295, Montpellier, Cedex 5, France. dany.jaffuel@wanadoo.fr.
Pulmonary Disorders and Respiratory Sleep Disorders Unit, Polyclinic Saint-Privat, 34760, Boujan sur Libron, France. dany.jaffuel@wanadoo.fr.

Carole Philippe (C)

Centre des pathologies du sommeil, Hôpital Universitaire de la Pitié Salpêtrière, AP-HP, Paris, France.

Claudio Rabec (C)

Pulmonary Department and Respiratory Critical Care Unit, University Hospital Dijon, Dijon, France.

Jean-Pierre Mallet (JP)

Department of Respiratory Diseases, Montpellier University Hospital, Hôpital Arnaud de Villeneuve, 371 avenue du Doyen Gaston Giraud, 34295, Montpellier, Cedex 5, France.

Marjolaine Georges (M)

Pulmonary Department and Respiratory Critical Care Unit, University Hospital Dijon, Dijon, France.

Stefania Redolfi (S)

Centre des pathologies du sommeil, Hôpital Universitaire de la Pitié Salpêtrière, AP-HP, Paris, France.

Alain Palot (A)

Clinique des Bronches, Allergies et du Sommeil, Assistance Publique Hôpitaux de Marseille, Marseille, France.
INSERM U1067, CNRS UMR 7333 Aix Marseille Université, 13015, Marseille, France.
Hôpital Saint-Joseph, 26, boulevard de Louvain, 13285, Marseille, France.

Carey M Suehs (CM)

Department of Respiratory Diseases, Montpellier University Hospital, Hôpital Arnaud de Villeneuve, 371 avenue du Doyen Gaston Giraud, 34295, Montpellier, Cedex 5, France.
Department of Medical Information, Montpellier University Hospital, Montpellier, France.

Erika Nogue (E)

Clinical Research and Epidemiology Unit (URCE), Montpellier University Hospital, Montpellier, France.

Nicolas Molinari (N)

Department of Medical Information, Montpellier University Hospital, Montpellier, France.
IMAG, CNRS, Montpellier University, Montpellier University Hospital, Montpellier, France.

Arnaud Bourdin (A)

Department of Respiratory Diseases, Montpellier University Hospital, Hôpital Arnaud de Villeneuve, 371 avenue du Doyen Gaston Giraud, 34295, Montpellier, Cedex 5, France.
PhyMedExp (INSERM U 1046, CNRS UMR9214), Montpellier University, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH